PyInvesting

Market research

000597.SHE Northeast Pharmaceutical Group Co., Ltd

SHE CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
7B
P/E ratio
31.4
Analyst target
Not available
Dividend yield
1.0%
Beta
0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Northeast Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 1.5% below its 200 day moving average.

From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.

Northeast Pharmaceutical Group Co., Ltd's total revenue sank by 12.6% to $2B since the same quarter in the previous year.

Its net income has increased by 938.9% to $11M since the same quarter in the previous year.

Finally, its free cash flow fell by 87.5% to $59M since the same quarter in the previous year.

Based on the above factors, Northeast Pharmaceutical Group Co., Ltd gets an overall score of 2/5.